Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17671992rdf:typepubmed:Citationlld:pubmed
pubmed-article:17671992lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:17671992lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:17671992lifeskim:mentionsumls-concept:C0019564lld:lifeskim
pubmed-article:17671992lifeskim:mentionsumls-concept:C0086045lld:lifeskim
pubmed-article:17671992lifeskim:mentionsumls-concept:C0243192lld:lifeskim
pubmed-article:17671992lifeskim:mentionsumls-concept:C0015283lld:lifeskim
pubmed-article:17671992lifeskim:mentionsumls-concept:C0079883lld:lifeskim
pubmed-article:17671992lifeskim:mentionsumls-concept:C0206128lld:lifeskim
pubmed-article:17671992lifeskim:mentionsumls-concept:C0220839lld:lifeskim
pubmed-article:17671992lifeskim:mentionsumls-concept:C0030685lld:lifeskim
pubmed-article:17671992lifeskim:mentionsumls-concept:C0205251lld:lifeskim
pubmed-article:17671992lifeskim:mentionsumls-concept:C0680255lld:lifeskim
pubmed-article:17671992lifeskim:mentionsumls-concept:C0391871lld:lifeskim
pubmed-article:17671992lifeskim:mentionsumls-concept:C1283071lld:lifeskim
pubmed-article:17671992lifeskim:mentionsumls-concept:C1963578lld:lifeskim
pubmed-article:17671992lifeskim:mentionsumls-concept:C1553423lld:lifeskim
pubmed-article:17671992pubmed:issue16lld:pubmed
pubmed-article:17671992pubmed:dateCreated2007-12-6lld:pubmed
pubmed-article:17671992pubmed:abstractTextPresynaptic NMDA autoreceptors regulating glutamate release have rarely been investigated. High-micromolar N-methyl-D-aspartate (NMDA) was reported to elicit glutamate release from hippocampal synaptosomes in a Ca(2+)-independent manner by reversal of excitatory amino acid transporters. The aim of this work was to characterize excitatory amino acid release evoked by low-micromolar NMDA from glutamatergic axon terminals. Purified rat hippocampal synaptosomes were prelabelled with [(3)H]D-aspartate ([(3)H]D-ASP) and exposed in superfusion to varying concentrations of NMDA in the presence of 1 microM glycine. The release of [(3)H]D-ASP and also that of endogenous glutamate provoked by 10 microM NMDA were external Ca(2+) dependent and sensitive to the NMDA channel blocker MK-801 but insensitive to the glutamate transporter inhibitor DL-TBOA, which, on the contrary, prevented the Ca(2+)-independent release evoked by 100 microM NMDA. The NMDA (10 microM) response was blocked by 1 nM Zn(2+) and 1 microM ifenprodil, compatible with the involvement of a NR1/NR2A/NR2B assembly, although the presence of two separate receptor populations, i.e., NR1/NR2A and NR1/NR2B, cannot be excluded. This response was strongly antagonized by submicromolar (0.01-1 microM) concentrations of kynurenic acid and was mimicked by quinolinic acid (1-100 microM) plus 1 microM glycine. Finally, the HIV-1 protein gp120 potently mimicked the NMDA co-agonists glycine and D-serine, being significantly effective at 30 pM. In conclusion, glutamatergic nerve terminals possess NMDA autoreceptors mediating different types of release when activated by different agonist concentrations: low-micromolar glutamate would potentiate glutamate exocytosis, whereas higher glutamate concentrations would also provoke carrier-mediated release.lld:pubmed
pubmed-article:17671992pubmed:languageenglld:pubmed
pubmed-article:17671992pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17671992pubmed:citationSubsetIMlld:pubmed
pubmed-article:17671992pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17671992pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17671992pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17671992pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17671992pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17671992pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17671992pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17671992pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17671992pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17671992pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17671992pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17671992pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17671992pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17671992pubmed:statusMEDLINElld:pubmed
pubmed-article:17671992pubmed:monthDeclld:pubmed
pubmed-article:17671992pubmed:issn0360-4012lld:pubmed
pubmed-article:17671992pubmed:authorpubmed-author:RaiteriMauriz...lld:pubmed
pubmed-article:17671992pubmed:authorpubmed-author:PittalugaAnna...lld:pubmed
pubmed-article:17671992pubmed:authorpubmed-author:LucciniElisaElld:pubmed
pubmed-article:17671992pubmed:authorpubmed-author:NeriElisaElld:pubmed
pubmed-article:17671992pubmed:authorpubmed-author:MusanteVeroni...lld:pubmed
pubmed-article:17671992pubmed:copyrightInfo(c) 2007 Wiley-Liss, Inc.lld:pubmed
pubmed-article:17671992pubmed:issnTypePrintlld:pubmed
pubmed-article:17671992pubmed:volume85lld:pubmed
pubmed-article:17671992pubmed:ownerNLMlld:pubmed
pubmed-article:17671992pubmed:authorsCompleteYlld:pubmed
pubmed-article:17671992pubmed:pagination3657-65lld:pubmed
pubmed-article:17671992pubmed:meshHeadingpubmed-meshheading:17671992...lld:pubmed
pubmed-article:17671992pubmed:meshHeadingpubmed-meshheading:17671992...lld:pubmed
pubmed-article:17671992pubmed:meshHeadingpubmed-meshheading:17671992...lld:pubmed
pubmed-article:17671992pubmed:meshHeadingpubmed-meshheading:17671992...lld:pubmed
pubmed-article:17671992pubmed:meshHeadingpubmed-meshheading:17671992...lld:pubmed
pubmed-article:17671992pubmed:meshHeadingpubmed-meshheading:17671992...lld:pubmed
pubmed-article:17671992pubmed:meshHeadingpubmed-meshheading:17671992...lld:pubmed
pubmed-article:17671992pubmed:meshHeadingpubmed-meshheading:17671992...lld:pubmed
pubmed-article:17671992pubmed:meshHeadingpubmed-meshheading:17671992...lld:pubmed
pubmed-article:17671992pubmed:meshHeadingpubmed-meshheading:17671992...lld:pubmed
pubmed-article:17671992pubmed:meshHeadingpubmed-meshheading:17671992...lld:pubmed
pubmed-article:17671992pubmed:meshHeadingpubmed-meshheading:17671992...lld:pubmed
pubmed-article:17671992pubmed:meshHeadingpubmed-meshheading:17671992...lld:pubmed
pubmed-article:17671992pubmed:meshHeadingpubmed-meshheading:17671992...lld:pubmed
pubmed-article:17671992pubmed:meshHeadingpubmed-meshheading:17671992...lld:pubmed
pubmed-article:17671992pubmed:meshHeadingpubmed-meshheading:17671992...lld:pubmed
pubmed-article:17671992pubmed:meshHeadingpubmed-meshheading:17671992...lld:pubmed
pubmed-article:17671992pubmed:meshHeadingpubmed-meshheading:17671992...lld:pubmed
pubmed-article:17671992pubmed:meshHeadingpubmed-meshheading:17671992...lld:pubmed
pubmed-article:17671992pubmed:year2007lld:pubmed
pubmed-article:17671992pubmed:articleTitleN-methyl-D-aspartate autoreceptors respond to low and high agonist concentrations by facilitating, respectively, exocytosis and carrier-mediated release of glutamate in rat hippocampus.lld:pubmed
pubmed-article:17671992pubmed:affiliationPharmacology and Toxicology Section, Department of Experimental Medicine, University of Genoa, Viale Cembrano 4, Genoa, Italy.lld:pubmed
pubmed-article:17671992pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17671992pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17671992lld:pubmed